The internationally active ENGEL Group has closed the 2025/26 financial year with revenue of EUR 1.4 billion, slightly below the previous year’s level (-6%). Recently, the company secured several major customer projects in the United States involving technologically advanced applications, underlining the region’s position as the Group’s most significant addressable market. Read more
As part of the Swiss Plastics Expo 2026, the Swiss Plastics Expo Award was presented for the third time on 22 January 2026, and the evolution from inject 4.0 to inject AI won the public vote.
Read more
![2025 04 engel trotz unsicheren zeiten mit wachsenden marktanteilen 1[1]](https://www.engel-injection.co.nz/wp-content/uploads/2025/05/2025-04-engel-trotz-unsicheren-zeiten-mit-wachsenden-marktanteilen-11-1-180x180.jpg)
Perfection in structure and design from a single mould and a single machine
Automotive interior components today often have to combine two worlds: high structural function and sophisticated decorative surfaces. By combining foammelt (physical or chemical foaming) and clearmelt (PUR flooding in the mould), ENGEL presents a solution that fulfils precisely this requirement – and does so in a single, fully integrated manufacturing step. This process integration enables high-strength, low-warpage functional parts with a visually flawless Class-A surface. Additional components, films or painting processes become unnecessary.
Read more
Be connected with the future of injection moulding
K Fair, Düsseldorf, 08 – 15 October 2025
Read more
ENGEL robots are characterized by their small footprint, long service live, efficient operation and reduced maintenance overheads. For maximum productivity.
Bioplastics offer the opportunity to combine injection moulding with sustainable raw materials. ENGEL has years of experience in the use of bioplastics and offers support in processing them correctly, safely and sustainably. Get started now with ENGEL solutions and expertise.
When ENGEL first unveiled a tie-bar-less injection moulding machine at the K trade fair in Düsseldorf in 1989, the reaction was mixed: technical fascination on one hand, open scepticism on the other. At that time, few would have predicted that this “revolutionary” design would evolve into one of the most successful technologies in injection moulding machinery. Today, 35 years later, ENGEL looks back on more than 85,000 tie-bar-less machines delivered worldwide – and continues to drive this innovation forward with a consistent focus on customer needs. At this year’s K 2025, ENGEL is presenting a world première: a new electric tie-bar-less injection moulding machine.
At K 2025, ENGEL will demonstrate how technological innovation, digital intelligence and sustainability can be effectively combined. The trade fair presentation focuses on industry-specific injection moulding solutions that enable companies to manufacture more efficiently, precisely and flexibly. ENGEL will showcase its technologies and solutions in practical operation – from the use of artificial intelligence in the running injection moulding process to highly integrated production cells for the automotive, medical, technical moulding and packaging sectors. Visitors are invited to gain a comprehensive overview of future-proof applications at ENGEL’s stand in Düsseldorf – and to witness the world premiere of a new electric tie-bar-less injection moulding machine.
![2025 06 engel eroeffnet neues tech center in frauenfeld 1[1]](https://www.engel-injection.co.nz/wp-content/uploads/2025/06/2025-06-engel-eroeffnet-neues-tech-center-in-frauenfeld-11-180x180.jpg)
With a festive ceremony and around 140 guests from the Swiss plastics industry, ENGEL has opened a new Tech Centre at its site in Frauenfeld. The inauguration also marks the 50th anniversary of ENGEL’s business operations in Switzerland. With this new technology centre, the Austrian injection moulding machine manufacturer is making a targeted investment in customer support, training and further education, as well as technological development – particularly in the highly regulated medical technology sector.